carbogen has been researched along with Cancer of Lung in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 7 (70.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bao, YN; Cui, YT; Huang, CX; Lin, Y; Tian, Y; Wang, XC; Yu, ZL; Zhang, JH | 1 |
Arnold, JF; Fidler, F; Flentje, M; Jakob, PM; Kotas, M; Pracht, ED | 1 |
Dewhirst, MW; Herman, TS; Holden, SA; Northey, D; Teicher, BA | 1 |
Beck-Bornholdt, HP; Krüll, A; Raabe, A; Rett, M | 1 |
Bernier, J; Bieri, S; Bolla, M; Denekamp, J; Dennis, MF; Hagen, F; Kocagöncü, O; Rojas, A; Stratford, MR | 1 |
Brauers, G; Chaplin, DJ; Collingridge, DR; Edwards, B; Hill, SA; Honess, DJ; Powell, NA | 1 |
Antognoni, P; Bernier, J; Dahl, O; Denekamp, J; Hamers, H; Horiot, JC; Kaanders, J; Piérart, M; Richaud, P; Rojas, A; Trovò, M; van Glabbeke, M | 1 |
Herman, TS; Menon, K; Teicher, BA | 1 |
Hishikawa-itoh, Y; Miyata, N | 1 |
Rose, CM; Teicher, BA | 1 |
2 trial(s) available for carbogen and Cancer of Lung
Article | Year |
---|---|
Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer.
Topics: Administration, Oral; Area Under Curve; Carbon Dioxide; Carcinoma; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Dose Fractionation, Radiation; Follow-Up Studies; Half-Life; Head and Neck Neoplasms; Humans; Lung Neoplasms; Nausea; Niacinamide; Oxygen; Pyridones; Radiation-Sensitizing Agents; Tablets; Time Factors; Treatment Outcome; Vomiting | 1998 |
ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC.
Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Carbon Dioxide; Carcinoma, Non-Small-Cell Lung; Dose Fractionation, Radiation; Humans; Lung Neoplasms; Middle Aged; Niacinamide; Oxygen; Pilot Projects; Radiation-Sensitizing Agents; Radiotherapy Dosage; Radiotherapy, High-Energy | 1999 |
8 other study(ies) available for carbogen and Cancer of Lung
Article | Year |
---|---|
The Effect of Carbogen Breathing on
Topics: A549 Cells; Animals; Carbon Dioxide; Carcinoma, Non-Small-Cell Lung; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Heterografts; Humans; Hypoxia; Immunohistochemistry; Lung; Lung Neoplasms; Mice; Mice, Nude; Oxygen; Positron-Emission Tomography; Tissue Distribution | 2019 |
Quantitative regional oxygen transfer imaging of the human lung.
Topics: Carbon Dioxide; Carcinoma, Non-Small-Cell Lung; Echo-Planar Imaging; Gases; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Oxygen; Oxygen Consumption; Reproducibility of Results; Respiration | 2007 |
Therapeutic effect of infused Fluosol-DA/carbogen with ephedrine, flunarizine, or nitroprusside.
Topics: Administration, Inhalation; Animals; Carbon Dioxide; Drug Combinations; Ephedrine; Flunarizine; Fluorocarbons; Hydroxyethyl Starch Derivatives; Injections, Intravenous; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Nitroprusside; Oxygen; Radiation-Sensitizing Agents; Time Factors | 1993 |
Combination of fractionated irradiation with nicotinamide and carbogen in R1H-tumours of the rat and its pulmonary metastases.
Topics: Animals; Carbon Dioxide; Combined Modality Therapy; Disease Models, Animal; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Female; Lung; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Experimental; Niacinamide; Oxygen; Radiation-Sensitizing Agents; Rats; Rhabdomyosarcoma; Skin Neoplasms; Treatment Outcome | 1997 |
Preclinical evaluation of the novel hypoxic marker 99mTc-HL91 (Prognox) in murine and xenograft systems in vivo.
Topics: Adenocarcinoma; Animals; Carbon Dioxide; Carcinoma; Cell Hypoxia; Colonic Neoplasms; Contrast Media; Humans; Lung Neoplasms; Mice; Mice, Inbred CBA; Mice, SCID; Niacinamide; Organotechnetium Compounds; Oximes; Oxygen; Radiopharmaceuticals; Sarcoma | 1998 |
Enhancement of fractionated radiation therapy by an experimental concentrated perflubron emulsion (Oxygent) in the Lewis lung carcinoma.
Topics: Animals; Blood Substitutes; Carbon Dioxide; Combined Modality Therapy; Drug Administration Schedule; Emulsions; Fluorocarbons; Hydrocarbons, Brominated; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Oxygen; Radiation-Sensitizing Agents | 1992 |
[Radiosensitization of Lewis lung tumor by perfluorochemical emulsion comparison between single and fractionated irradiation].
Topics: Animals; Carbon Dioxide; Dose-Response Relationship, Drug; Emulsions; Female; Fluorocarbons; Lung Neoplasms; Mice; Oxygen; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1990 |
Effects of dose and scheduling on growth delay of the Lewis lung carcinoma produced by the perfluorochemical emulsion, Fluosol-DA.
Topics: Animals; Carbon Dioxide; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Fluorocarbons; Hydroxyethyl Starch Derivatives; Lung Neoplasms; Mice; Oxygen; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1986 |